Kara-Louise Royle

8PUBLICATIONS
38CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMedical genetics (excl. cancer genetics)Cancer therapy (excl. chemotherapy and radiation therapy)Flight dynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2026
Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data.

|Oct 24, 2025
How should overall survival be analysed in randomised clinical trials in cancer if participants receive subsequent treatment lines? A stakeholder consultation.

Kara-Louise Royle, Peter Wheatstone, David Meads

|Jul 15, 2025
Incorporation of Patient and Public Involvement in Statistical Methodology Research: Summary of Workshop Proceedings.

Aiden Smith, Hannah Worboys, Samina Begum

|Sep 09, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Fiona Collinson, Kara-Louise Royle, Jayne Swain

|Nov 05, 2023
How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review.

Kara-Louise Royle, David Meads, Jennifer K Visser-Rogers

|Nov 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial.

Kara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy

Pageof 2

Frequent Collaborators

2 joint publications

Amy Beth Coulson

1 joint publications

Holger W Auner

1 joint publications

Fiona Collinson

1 joint publications

Jayne Swain